Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RLKMU
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
IBI343
|
|||||
| Synonyms |
IBI-343; IBI 343
Click to Show/Hide
|
|||||
| Organization |
Innovent Biologics, Inc.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 3 Indication(s)
Gastric cancer [ICD11:2B72]
Phase 1
Gastroesophageal junction cancer [ICD11:2B71]
Phase 1
Pancreatic ductal adenocarcinoma [ICD11:2C10]
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Claudin-18.2 (CLDN18.2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.